Harsco Corporation HSC
Set alert
At close · Jun 16
52-week range unavailable
- Open
- 9.03
- Prev close
- 9.15
- Mkt cap
- 729.61M
- Vol
- 1.94M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.67
- High
- 9.18
- Forward P/E
- 26.91
- Beta
- 2.03
- Short ratio
- 4.19
- Inst. own
- 96.83%
- Dividend
- 0.00
- Ex-div date
- Jan 12, 2016
- Earnings
- Aug 1, 2023
- 50-d avg
- 8.76
- 200-d avg
- 7.18
- 1y target
- 13.00
Key statistics
- Market cap
- 729.61M
- Enterprise value
- 2.16B
- Trailing P/E
- 0.00
- Forward P/E
- 26.91
- PEG ratio
- -4.73
- Price / sales
- 0.38
- Price / book
- 1.28
- EPS (TTM)
- -1.80
- Beta
- 2.03
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -7.75%
- Revenue (TTM)
- 1.93B
- Revenue growth
- 9.50%
- Free cash flow
- 189.27M
- Total cash
- 93.07M
- Total debt
- 1.47B
- Return on equity
- -19.35%
- Shares outstanding
- 79.74M
- Short % of float
- 4.27%
- 50-day average
- 8.76
- 200-day average
- 7.18
Analyst view
Consensus: buy
- Target (low)
- 9.00
- Target (mean)
- 13.00
- Target (high)
- 19.00
- Strong buy1
- Buy3
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 1, 2023
Expected Aug 1, 2023. Consensus EPS estimate -0.05.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 1, 2023 | Jun 1, 2023 | -0.07 | — | — | — |
| May 3, 2023 | Mar 1, 2023 | -0.28 | — | — | — |
| Feb 27, 2023 | Dec 1, 2022 | -0.04 | — | — | — |
| Nov 1, 2022 | Sep 1, 2022 | -0.07 | — | — | — |
| Aug 2, 2022 | Jun 1, 2022 | 0.01 | — | — | — |
| May 3, 2022 | Mar 1, 2022 | 0.03 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 28, 2023 | BMO Capital | main | — | Market Perform |
| Jul 20, 2022 | DA Davidson | main | — | Buy |
| Jul 18, 2022 | Barrington Research | main | — | Outperform |
| Jul 12, 2022 | BMO Capital | init | — | Market Perform |
| Mar 30, 2022 | DA Davidson | init | — | Buy |
| Nov 8, 2021 | Argus Research | down | Buy | Hold |
About Harsco Corporation
Enviri Corporation provides environmental solutions for industrial and specialty waste streams in the United States and internationally. The company operates through two segments: Harsco Environmental and Harsco Clean Earth. The Harsco Environmental segment offers on-site services under long-term contracts for material logistics, product quality improvement, and resource recovery for iron, steel, and metals manufacturing; manufactures and sells industrial abrasives, roofing granules, aluminum dross, and scrap processing systems; and produces value-added downstream products from industrial waste-stream. The Harsco Clean Earth segment provides specialty waste processing, treatment, and recycling and beneficial reuse solutions for waste needs, such as hazardous, non-hazardous, and contaminated soils and dredged materials. The company was formerly known as Harsco Corporation and changed its name to Enviri Corporation in June 2023. The company was founded in 1853 and is headquartered in Philadelphia, Pennsylvania.
- Sector
- Industrials
- Industry
- Waste Management
- Country
- United States
- Website
- enviri.com
News
- Harsco Environmental Secures 10-Year Contract Renewal with EZS
- Harsco Environmental Recognized in Three Newsweek America's Greatest Workplaces Awards
- Harsco Environmental Secures New 10-Year Contract With Lloyds Metals and Energy Limited
- Harsco Environmental Expands Presence in Central Europe With Two New Contracts in Slovakia
- Editas Medicine to Present in vivo HSC Delivery, Editing, and Biodistribution Data at the European Hematology Association 2025 Congress in June
- Harsco Environmental Opens First SteelPhalt™ Plant Outside the UK
- Harsco Environmental Secures Contract with İzmir Demir Çelik Sanayi A.Ş. (İDÇ)
- Orchard Therapeutics Appoints Robin Kenselaar to Chief Commercial Officer and Announces Multiple Business Updates Pertaining to its Approved HSC Gene Therapy for MLD
- Orchard Therapeutics Announces Multiple Data Presentations and Receives 2025 New Treatment Award at the 21st Annual WORLDSymposium™
- BioLineRx Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell (HSC) Mobilization For Gene Therapy Applications in Sickle Cell Disease (SCD)
Your note
Sign in to keep a note on HSC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| EARL JAMES F | Director | Conversion of Exercise of derivative security | Apr 18, 2023 | 67,783 |
| EDDY KATHY G | Director | Conversion of Exercise of derivative security | Apr 18, 2023 | 37,786 |
| EVERITT DAVID C | Director | Conversion of Exercise of derivative security | Apr 18, 2023 | 0 |
| GRASBERGER F NICHOLAS III | Chief Executive Officer | Conversion of Exercise of derivative security | Mar 9, 2023 | 771,228 |
| HAZNEDAR CAROLANN I | Director | Conversion of Exercise of derivative security | Apr 18, 2023 | 0 |
| HOCHMAN RUSSELL C | General Counsel | Conversion of Exercise of derivative security | Mar 9, 2023 | 53,729 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 17.83% | 14,217,478 | 130.09M | Mar 30, 2023 |
| Vanguard Group, Inc. (The) | 11.69% | 9,318,322 | 85.26M | Mar 30, 2023 |
| Barrow, Hanley Mewhinney & Strauss, LLC | 6.15% | 4,905,075 | 44.88M | Mar 30, 2023 |
| Cooper Creek Partners Management LLC | 4.02% | 3,207,417 | 29.35M | Mar 30, 2023 |
| Neuberger Berman Group, LLC | 3.98% | 3,172,359 | 29.03M | Mar 30, 2023 |
| State Street Corporation | 3.70% | 2,953,929 | 27.03M | Mar 30, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Core S&P Smallcap ETF | 7.61% | 6,053,607 | 55.39M | Feb 27, 2023 |
| Vanguard Total Stock Market Index Fund | 3.22% | 2,563,153 | 23.45M | Dec 30, 2022 |
| American Beacon Small Cap Value Fd | 3.08% | 2,449,551 | 22.41M | Jan 30, 2023 |
| Federated Hermes MDT Small Cap Core Fund | 2.75% | 2,188,186 | 20.02M | Jan 30, 2023 |
| Vanguard Small-Cap Index Fund | 2.58% | 2,047,648 | 18.74M | Dec 30, 2022 |
| iShares Russell 2000 ETF | 2.20% | 1,745,142 | 15.97M | Feb 27, 2023 |